MedTrace Logo

INSPIRIS RESILIA Valve in Pulmonary Position

NCT05583656 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-10-18

No results posted yet for this study

Summary

In this trial we intend to evaluate the safety and effectiveness of the INSPIRIS valve prothesis in the pulmonary position in patients of five years or older, with congenital or acquired pulmonary valve disease, requiring replacement of their native or prosthetic pulmonary valve.

Conditions

  • Pulmonary Valve Disorder
  • Congenital Heart Disease

Interventions

PROCEDURE

Pulmonary valve replacement

Surgical replacement of the pulmonary valve using the Edwards Inspiris Resilia prosthesis.

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-12
Primary Completion
2023-08-01
Completion
2024-02-01

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05583656 on ClinicalTrials.gov